Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 533 of 1,261
  1. US 2018326059

    COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

    GANYMED PHARMACEUTICALS AG [DE] · Granted Nov 15, 2018 · Expires Nov 10, 2038

    granted
  2. US 10125131

    Selective HDAC3 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  3. US 10125128

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  4. US 10123984

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  5. US 10123529

    Compounds for protection of cells

    Sulfateq B.V. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  6. US 10123518

    Genetically modified non-human animals and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  7. US 10125167

    Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  8. US 10124109

    Method and device for treating allergic reactions and difficult-to-manage respiratory diseases

    Pharmaceutical Design, LLC · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  9. US 10125098

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  10. US 10125105

    Triazabutadienes as cleavable cross-linkers

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  11. US 10123947

    Dental cement

    KURARAY NORITAKE DENTAL INC. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  12. US 10123979

    Methods of treating developmental disorders with biguanides

    OVID THERAPEUTICS INC. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  13. US 10125112

    Modulators of the relaxin receptor 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  14. US 10123759

    Systems, compositions, and methods for local imaging and treatment of pain

    The Regents of the University of California · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  15. US 10126309

    Method for the detection of an albumin isoform

    The Board of Regents of the University of Texas System · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  16. US 10123974

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  17. US 10125102

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  18. US 10125193

    Chimeric antigen receptors and methods of making

    The Board of Regents of the University of Texas System · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  19. US 10125188

    Human antibodies to respiratory syncytial virus F protein and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  20. US 10125361

    Compositions and methods of nucleic acid-targeting nucleic acids

    Caribou Biosciences, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  21. US 10125172

    Conformationally stabilized RSV pre-fusion F proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  22. US 10125171

    Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

    Apellis Pharmaceuticals, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  23. US 10125145

    5-HT3 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  24. US 10125134

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.